Answers are grounded in this paper and cite their sources.
Explores tumor-specific synergistic treatment in pancreatic cancer, suggesting novel therapy options.
Pancreatic cancer remains highly refractory to conventional therapies owing to its immunosuppression of the tumor microenvironment (TME) and dense stromal structure. Nanomaterial-based strategies offer promising avenues for integrating multimodal treatment...
No takes yet. Share an insight, caveat, or question.
Yin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: